Abstract
The concentration of 170H-progesterone was measured in amniotic fluid samples collected from 55 mothers who had previously had a child with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. In eight pregnancies the levels of 170H-progesterone were raised; the parents elected to terminate in four and examinations of the fetus confirmed the diagnosis of congenital adrenal hyperplasia. In each case, the affected sib was a salt loser. The remaining four affected pregnancies proceeded to term and each infant had salt losing 21-hydroxylase deficiency. All 47 infants predicted to be unaffected were normal at birth. However, an increased plasma concentration of 170H-progesterone was documented in a male non-salt loser at three months of age. Prenatal diagnosis of congenital adrenal hyperplasia by amniotic fluid steroid analysis is reliable only for the salt losing variant of 21-hydroxylase deficiency. Of the affected sibs in this study, 20% died during infancy in a salt losing crisis. This simple and rapid prenatal test is sufficiently reliable to predict the group of infants most at risk in early infancy.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bowen D. M., White P., Spillane J. A., Goodhardt M. J., Curzon G., Iwangoff P., Meier-Ruge W., Davison A. N. Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet. 1979 Jan 6;1(8106):11–14. doi: 10.1016/s0140-6736(79)90454-9. [DOI] [PubMed] [Google Scholar]
- Dyas J., Read G. F., Guha-Maulik T., Hughes I. A., Riad-Fahmy D. A rapid assay for 17 alpha OH-progesterone in plasma, saliva and amniotic fluid using a magnetisable solid-phase antiserum. Ann Clin Biochem. 1984 Sep;21(Pt 5):417–424. doi: 10.1177/000456328402100514. [DOI] [PubMed] [Google Scholar]
- Forest M. G., Bétuel H., Couillin P., Boué A. Prenatal diagnosis of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency by steroid analysis in the amniotic fluid of mid-pregnancy: comparison with HLA typing in 17 pregnancies at risk for CAH. Prenat Diagn. 1981 Jul;1(3):197–207. doi: 10.1002/pd.1970010305. [DOI] [PubMed] [Google Scholar]
- Hughes I. A. Congenital and acquired disorders of the adrenal cortex. Clin Endocrinol Metab. 1982 Mar;11(1):89–125. doi: 10.1016/s0300-595x(82)80039-x. [DOI] [PubMed] [Google Scholar]
- Hughes I. A., Riad-Fahmy D., Griffiths K. Plasma 17OH-progesterone concentrations in newborn infants. Arch Dis Child. 1979 May;54(5):347–349. doi: 10.1136/adc.54.5.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nagamani M., McDonough P. G., Ellegood J. O., Mahesh V. B. Maternal and amniotic fluid 17 alpha-hydroxyprogesterone levels during pregnancy: diagnosis of congenital adrenal hyperplasia in utero. Am J Obstet Gynecol. 1978 Apr 1;130(7):791–794. doi: 10.1016/0002-9378(78)90010-8. [DOI] [PubMed] [Google Scholar]
- New M. I. Clinical and endocrinological aspects of 21-hydroxylase deficiency. Ann N Y Acad Sci. 1985;458:1–27. doi: 10.1111/j.1749-6632.1985.tb14585.x. [DOI] [PubMed] [Google Scholar]
- New M. I., Speiser P. W. Genetics of adrenal steroid 21-hydroxylase deficiency. Endocr Rev. 1986 Aug;7(3):331–349. doi: 10.1210/edrv-7-3-331. [DOI] [PubMed] [Google Scholar]
- Pang S., Pollack M. S., Loo M., Green O., Nussbaum R., Clayton G., Dupont B., New M. I. Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia. Ann N Y Acad Sci. 1985;458:111–129. doi: 10.1111/j.1749-6632.1985.tb14597.x. [DOI] [PubMed] [Google Scholar]
- Serón-Ferré M., Jaffe R. B. The fetal adrenal gland. Annu Rev Physiol. 1981;43:141–162. doi: 10.1146/annurev.ph.43.030181.001041. [DOI] [PubMed] [Google Scholar]
- Youssefnejadian E., David R. Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone. Clin Endocrinol (Oxf) 1975 Jul;4(4):451–454. doi: 10.1111/j.1365-2265.1975.tb01553.x. [DOI] [PubMed] [Google Scholar]